Effectiveness of long-term rosiglitazone administration in patients with Cushing's disease

被引：11

作者：

Cannavò, S ^{[1
]}

Arosio, M

Almoto, B

Dall'Asta, C

Ambrosi, B

机构：

[1] Univ Messina, Dept Med & Pharmacol, Endocrinol Sect, Messina, Italy

[2] Univ Milan, Osped Maggiore, IRCCS, Inst Endocrine Sci, Milan, Italy

[3] Osped San Giuseppe Fatebenefratelli, AFaR, Endocrinol Unit, Milan, Italy

[4] Univ Milan, Ist Policlin San Donato, Dept Med & Surg Sci, Endocrinol Unit, Milan, Italy

来源：

CLINICAL ENDOCRINOLOGY | 2005年 / 63卷 / 01期

关键词：

D O I：

10.1111/j.1365-2265.2005.02285.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：118 / 119

页数：3

共 5 条

[1] Effects of chronic administration of PPAR-γ ligand rosiglitazone in Cushing's disease [J].

Ambrosi, B ;

Dall'Asta, C ;

Cannavò, S ;

Libé, R ;

Vigo, T ;

Epaminonda, P ;

Chiodini, L ;

Ferrero, S ;

Trimarchi, F ;

Arosio, M ;

Beck-Peccoz, P .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (02) :173-178

[2]

GIRALDI FP, 2004, P 11 ENEA M SORR IT

[3] Functional PPAR-γ receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas [J].

Heaney, AP ;

Fernando, M ;

Yong, WH ;

Melmed, S .

NATURE MEDICINE, 2002, 8 (11) :1281-1287

[4] Pre-operative medical therapy with rosiglitazone in two patients with newly diagnosed pituitary-dependent Cushing's syndrome [J].

Hull, SSA ;

Sheridan, B ;

Atkinson, AB .

CLINICAL ENDOCRINOLOGY, 2005, 62 (02) :259-261

[5] Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease [J].

Suri, D ;

Weiss, RE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1340-1346

← 1 →